CT45A1 and cancer: This study proposed CT45 as a potential therapeutic target on the basis of its synergistic effect on carboplatin-induced hyperactivation of DNA damage pathways, and its role as a cancer antigen to facilitate anti-tumor cytotoxic T cells (154).